Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.

Autor: Cressatti M; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada.; Department of Medicine, School of Medicine, Queen's University, Kingston, ON, Canada., Pinilla-Monsalve GD; Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada., Blais M; Axe Neurosciences du Centre de recherche du CHU de Québec - Université Laval, Québec, QC, Canada., Normandeau CP; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada., Degroot C; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada., Kathol I; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada., Bogard S; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada., Bendas A; Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada., Camicioli R; Department of Medicine, Division of Neurology, University of Alberta, Edmonton, AB, Canada.; Parkinson and Movement Disorders Program and the Complex Neurologic Symptoms Clinic, Kaye Edmonton Clinic, University of Alberta, Edmonton, AB, Canada.; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada., Dupré N; Axe Neurosciences du Centre de recherche du CHU de Québec - Université Laval, Québec, QC, Canada.; Faculty of Medicine, Department of Medicine, Université Laval, Québec, QC, Canada., Gan-Or Z; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada., Grimes DA; Division of Neurology and Program in Neuroscience, The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada., Kalia LV; Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.; Morton and Gloria Shulman Movement Disorder Unit and the E. J. Safra Parkinson Disease Program, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada., MacDonald PA; Brain and Mind Institute, University of Western Ontario, London, ON, Canada.; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada., McKeown MJ; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Vancouver, BC, Canada., Martino D; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada., Miyasaki JM; Department of Medicine, Division of Neurology, University of Alberta, Edmonton, AB, Canada.; Parkinson and Movement Disorders Program and the Complex Neurologic Symptoms Clinic, Kaye Edmonton Clinic, University of Alberta, Edmonton, AB, Canada.; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada., Schlossmacher MG; Division of Neurology and Program in Neuroscience, The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada., Stoessl AJ; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia & Vancouver Coastal Health, Vancouver, BC, Canada., Strafella AP; Morton and Gloria Shulman Movement Disorder Unit and the E. J. Safra Parkinson Disease Program, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, ON, Canada.; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.; Division of Brain, Imaging and Behaviour - Systems Neuroscience, Krembil Brain Institute, University Health Network, University of Toronto, Toronto, ON, Canada.; Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Toronto, ON, Canada., Fon EA; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada., Monchi O; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Hotchkiss Brain Institute, Cumming School of Medicine, Calgary, AB, Canada.; Centre de Recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.; Département de radiologie, radio-oncologie et médecine nucléaire, Faculté de médecine, Université de Montréal, Montréal, QC, Canada.

Publikováno v: Journal of Parkinson's disease [J Parkinsons Dis] 2024; Vol. 14 (7), pp. 1481-1494.

A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis.

Autor: Hawken ER; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada., Normandeau CP; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada., Gardner Gregory J; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada., Cécyre B; École d'optométrie, Université de Montréal, Montréal, QC, Canada., Bouchard JF; École d'optométrie, Université de Montréal, Montréal, QC, Canada., Mackie K; Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana, USA., Dumont ÉC; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada. eric.dumont@queensu.ca.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2019 Jun; Vol. 44 (7), pp. 1274-1283. Date of Electronic Publication: 2019 Jan 07.

Neurotensin and dynorphin Bi-Directionally modulate CeA inhibition of oval BNST neurons in male mice.

Autor: Normandeau CP; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada., Torruella Suárez ML; Program in Neurobiology, School of Medicine, University of North Carolina at Chapel Hill, USA., Sarret P; Department of Pharmacology & Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada., McElligott ZA; Bowles Center for Alcohol Studies and Departments of Psychiatry and Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, USA., Dumont EC; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada. Electronic address: eric.dumont@queensu.ca.

Publikováno v: Neuropharmacology [Neuropharmacology] 2018 Dec; Vol. 143, pp. 113-121. Date of Electronic Publication: 2018 Sep 21.

Advances in understanding and treating mental illness: proceedings of the 40th Canadian College of Neuropsychopharmacology Annual Meeting Symposia.

Autor: Normandeau CP; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Naumova D; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Thompson SL; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Ebrahimzadeh M; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Liu YQ; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Reynolds L; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Ren HY; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Hawken ER; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren)., Dumont ÉC; From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ont., Canada (Normandeau, Qing Liu, Dumont); the Department of Human Genetics, McGill University, Montreal, Que., Canada (Naumova); the Departments of Psychiatry, Neurology and Neurosurgery, McGill University, Montreal, Que., Canada (Reynolds); the Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont., Canada (Thompson); the Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ont., Canada (Ebrahimzadeh); and the Department of Psychiatry, University of Alberta, Edmonton, Alta., Canada (Ren).

Publikováno v: Journal of psychiatry & neuroscience : JPN [J Psychiatry Neurosci] 2017 Sep; Vol. 42 (5), pp. 353-358.

D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats.

Autor: Krawczyk M; Department of Biomedical and Molecular Sciences and Center for Neuroscience Studies, Queen's University, Kingston, Ontario K7L 3N6, Canada., Mason X, DeBacker J, Sharma R, Normandeau CP, Hawken ER, Di Prospero C, Chiang C, Martinez A, Jones AA, Doudnikoff É, Caille S, Bézard E, Georges F, Dumont ÉC

Publikováno v: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2013 Jul 17; Vol. 33 (29), pp. 11960-71.